advertising
-
1
Armstrong GL, Pinner RW: Outpatient visits for infectious diseases in the United States, 1980 through 1996. .Arch Intern Med 159::2531. ,1999. .
-
2
Neiderman MS, Mandell LA, Anzueto A, et al: Guidelines for the management of adults with community-acquired lower respiratory tract infections: diagnosis, assessment of severity, antimicrobial therapy and prevention. .Am J Respir Crit Care Med 163::1730. ,2001. .
-
3
Simonsen L, Conn LA, Pinner RW, et al: Trends in infectious disease hospitalizations in the United States, 1980-1994. .Arch Intern Med 158::1923. ,1998. .
-
4
File TM: The epidemiology of respiratory tract infections. .Semin Respir Infect 15::184. ,2000. .
-
5
Bartlett JG, Breiman RF, Mandell LA, et al: Community-acquired pneumonia in adults: guidelines for management. .Clin Infect Dis 26::811. ,1998. .
-
6
Fine MJ, Smith MA, Carson CA, et al: Prognosis and outcomes of patients with community-acquired pneumonia. .JAMA 275::134. ,1996. .
-
7
Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies: a consensus statement, American Thoracic Society, November 1995. .Am J Respir Crit Care Med 153::1711. ,1996. .
-
8
American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. .Am J Respir Crit Care Med 152::S77. ,1995. .
-
9
Mannino DM: COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. .Chest 121 (suppl)::121S. ,2002. .
-
10
National Health Interview Survey: research for the 1995–2004 redesign. .Vital Health Stat 2 126::1. ,1999. .
-
11
Beck GJ, Doyle CA, Schachter EN: Smoking and lung function. .Am Rev Respir Dis 123:: 149. ,1981. .
-
12
Fletcher C, Peto R, Tinker C, et al: The Natural History of Chronic Bronchitis: An Eight-Year Study of Chronic Obstructive Lung Disease in Working Men in London, p 272, Oxford University Press, Oxford, England, 1976..
-
13
Sandford AJ, Weir TD, Pare PD: Genetic risk factors for chronic obstructive pulmonary disease. .Eur Respir J 10::1380. ,1997. .
-
14
Connors AF Jr, Dawson NV, Thomas C, et al: Outcomes following acute exacerbation of severe chronic obstructive lung disease: the SUPPORT Investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). .Am J Respir Crit Care Med 154::959. ,1996. .
-
15
Ferguson GT: Update on pharmacologic therapy for chronic obstructive pulmonary disease. .Clin Chest Med 21::723. ,2000. .
-
16
Belman MJ, Botnick WC, Shin JW: Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. .Am J Respir Crit Care Med 153::967. ,1996. .
-
17
Niewoehner DE, Erbland ML, Deupree RH, et al: Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. .N Engl J Med 340::1941. ,1999. .
-
18
Bourjeily G, Rochester C: Exercise training in chronic obstructive pulmonary disease. .Clin Chest Med 21::763. ,2000. .
-
19
National Asthma Education and Prevention Program: Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma, National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD, 1997..
-
20
Szefler SJ: The natural history of asthma and early intervention. .J Allergy Clin Immunol 109 (suppl)::S549. ,2002. .
-
21
Beasley R: The burden of asthma with specific reference to the United States. .J Allergy Clin Immunol 109 (suppl)::S482. ,2002. .
-
22
Cohen NH, Eigen H, Shaughnessy TE: Status asthmaticus. .Crit Care Clin 13::459. ,1997. .
-
23
Reed CE: The natural history of asthma in adults: the problem of irreversibility. .J Allergy Clin Immunol 103:: 539. ,1999. .
-
24
Hyers TM: Venous thromboembolism. .Am J Respir Crit Care Med 159::1. ,1999. .
-
25
Kim V, Spandorfer J: Epidemiology of venous thromboembolic disease. .Emerg Med Clin North Am 19::839. ,2001. .
-
26
Rocha AT, Tapson VF: Venous thromboembolism in intensive care patients. .Clin Chest Med 24::103. ,2003. .
-
27
Hirsh J, Dalen J, Guyatt G: The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis: American College of Chest Physicians. .Chest 119 (suppl)::1S. ,2001. .
Pulmonary Disease
Pneumonia, Chronic Obstructive Pulmonary Disease, Asthma, and Thromboembolic Disease
Search for other papers by Vera A. De Palo in
Current site
Google Scholar
PubMed
Although many medical problems are generally managed in concert with a general medical physician, it is important for the podiatric physician to be familiar with some of the major diseases of the lung. Pneumonia, an infectious process within the lung, is the sixth-leading overall cause of death. Antibiotic treatment, oxygen administration, and supportive care are the mainstays of its therapy. Chronic obstructive pulmonary disease presents as a spectrum from chronic bronchitis, with a greater inflammatory component, to emphysema, with a more significant destructive component. Asthma, often a more episodic chronic obstructive disease, is characterized by inflammation of the airways leading to their narrowing. The work of breathing is often increased in these diseases, and treatment is with combination therapies with a focus on smoking cessation. Thromboembolic disease, the occlusion of blood vessels with consequent interruption of blood flow, may occur in a patient with risk factors, especially after surgery. Treatment is with anticoagulation agents or in some cases with thrombolysis. Prophylaxis is key. (J Am Podiatr Med Assoc 94(2): 157-167, 2004)
advertising
